Gerrit A Meijer Selected Research

Calcibiotic Root Canal Sealer

2/2021	Diagnostic yield of colonoscopy surveillance in testicular cancer survivors treated with platinum-based chemotherapy: study protocol of a prospective cross-sectional cohort study.
1/2020	Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression.
1/2020	Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression.
11/2018	Consensus molecular subtype classification of colorectal adenomas.
1/2018	World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer.
1/2018	Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.
1/2018	Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.
7/2015	Serrated neoplasia-role in colorectal carcinogenesis and clinical implications.
1/2015	Oncogenic Role of miR-15a-3p in 13q Amplicon-Driven Colorectal Adenoma-to-Carcinoma Progression.
1/2014	Chromosome 20 aberrations at the diploid-aneuploid transition in sporadic colorectal cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gerrit A Meijer Research Topics

Disease

87	Neoplasms (Cancer) 12/2022 - 12/2003
53	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 07/2005
34	Adenoma (Adenomas) 04/2021 - 01/2006
24	Carcinoma (Carcinomatosis) 01/2020 - 10/2005
21	Colonic Neoplasms (Colon Cancer) 12/2022 - 06/2009
10	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2007
9	Adenocarcinoma 08/2021 - 01/2006
8	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2013
7	Microsatellite Instability 11/2018 - 02/2012
6	Carcinogenesis 02/2021 - 01/2009
5	Breast Neoplasms (Breast Cancer) 09/2012 - 12/2003
5	Genomic Instability 01/2011 - 01/2005
4	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 02/2017
4	Chromosomal Instability (Chromosome Stability) 05/2014 - 04/2010
4	Chromosome Aberrations (Chromosome Abnormalities) 03/2009 - 11/2005
3	Polyps 04/2021 - 01/2006
3	Lung Neoplasms (Lung Cancer) 01/2021 - 10/2011
3	Hypoxia (Hypoxemia) 01/2016 - 12/2003
3	Aneuploidy (Aneuploid) 01/2014 - 09/2006
2	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 03/2009
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2021
2	Metaplasia 05/2014 - 01/2004
2	Atrophy 01/2013 - 01/2004
2	Pulmonary Hypertension 08/2011 - 01/2010
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2010 - 01/2009
2	Celiac Disease (Celiac Sprue) 05/2007 - 12/2005
2	Melanoma (Melanoma, Malignant) 09/2006 - 10/2005
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 04/2021
1	Testicular Neoplasms (Testicular Cancer) 02/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Pleural Effusion (Pleural Effusions) 02/2019

Drug/Important Bio-Agent (IBA)

56	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2005
34	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2003
32	Biomarkers (Surrogate Marker)IBA 12/2022 - 11/2007
18	Calcibiotic Root Canal SealerIBA 02/2021 - 12/2007
12	Messenger RNA (mRNA)IBA 01/2017 - 07/2008
11	ParaffinIBA 01/2021 - 12/2003
10	Biological ProductsIBA 01/2021 - 02/2008
10	Formaldehyde (Formol)FDA Link 01/2021 - 11/2008
6	Cell-Free Nucleic AcidsIBA 01/2021 - 01/2019
6	ErbB Receptors (EGF Receptor)IBA 12/2020 - 04/2006
6	Aurora Kinase AIBA 01/2018 - 04/2010
5	RNA (Ribonucleic Acid)IBA 01/2020 - 11/2005
5	MicroRNAs (MicroRNA)IBA 01/2018 - 07/2008
4	Procarbazine (Matulane)FDA Link 01/2022 - 02/2017
3	Irinotecan (Camptosar)FDA LinkGeneric 12/2022 - 09/2016
3	Hemoglobins (Hemoglobin)IBA 01/2021 - 10/2011
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 05/2008
3	AntibodiesIBA 12/2020 - 01/2008
3	Tyrosine Kinase InhibitorsIBA 02/2019 - 04/2006
3	Peptides (Polypeptides)IBA 10/2018 - 12/2005
3	Small Interfering RNA (siRNA)IBA 10/2017 - 06/2009
3	Versicans (Versican)IBA 01/2017 - 09/2012
3	ChromatinIBA 05/2014 - 02/2007
3	ProteomeIBA 03/2014 - 05/2010
3	Cyclin D1IBA 07/2012 - 12/2003
2	Secretory Leukocyte Peptidase InhibitorIBA 01/2022 - 10/2020
2	Circulating Tumor DNAIBA 01/2021 - 12/2020
2	Bevacizumab (Avastin)FDA Link 01/2021 - 10/2018
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2018 - 04/2008
2	Complement System Proteins (Complement)IBA 12/2017 - 09/2014
2	LumicanIBA 01/2017 - 12/2013
2	Glycoproteins (Glycoprotein)IBA 01/2017 - 12/2013
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2016 - 11/2007
2	CarbohydratesIBA 09/2015 - 07/2005
2	Carrier Proteins (Binding Protein)IBA 05/2014 - 06/2009
2	A-Form DNA (A-DNA)IBA 05/2014 - 08/2011
2	Cetuximab (Erbitux)FDA Link 07/2012 - 04/2008
2	Carcinoembryonic AntigenIBA 07/2012 - 07/2005
2	Polysaccharides (Glycans)IBA 07/2012 - 08/2007
2	AntigensIBA 07/2012 - 10/2005
2	Mucin-1 (CA 15-3 Antigen)IBA 07/2012 - 08/2007
2	OligonucleotidesIBA 02/2012 - 03/2009
2	MonocrotalineIBA 08/2011 - 01/2010
2	Nonsense Codon (Nonsense Mutation)IBA 03/2010 - 06/2009
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2009 - 06/2007
2	Gemcitabine FDA Link 04/2008 - 11/2005
2	C-Type Lectins (C-Type Lectin)IBA 08/2007 - 07/2005
1	NexusIBA 01/2022
1	theasinensin AIBA 04/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 04/2021
1	PlatinumIBA 02/2021
1	Cisplatin (Platino)FDA LinkGeneric 02/2021
1	CDX2 Transcription FactorIBA 01/2021
1	SerpinsIBA 01/2021
1	N 30IBA 01/2021
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2021
1	HaptoglobinsIBA 01/2020
1	GenieIBA 12/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2018
1	Phosphotransferases (Kinase)IBA 10/2018
1	Dasatinib (BMS 354825)FDA Link 10/2018

Therapy/Procedure

18	Therapeutics 12/2022 - 10/2005
11	Drug Therapy (Chemotherapy) 02/2021 - 04/2006
10	Adjuvant Chemotherapy 04/2022 - 01/2012
5	Radiotherapy 01/2022 - 01/2012
4	Ligation 01/2018 - 11/2008
3	Neoadjuvant Therapy 08/2021 - 05/2015
2	Immunotherapy 01/2016 - 02/2012